SENORESSenores Pharmaceuticals Ltd.
Senores Pharmaceuticals plans ₹43 crore capacity expansion at subsidiaries
Havix Group and Apnar Pharma plan capacity increases, and Ratnatris adds a prefilled syringe line, all targeted for completion by end of March 2027, the company said.
- Guidance
- pharmaceuticals
